Key Takeaways
- Volume-led recovery, pricing still a drag: Non-energy volumes rebounded YoY and QoQ, but persistent Chinese overcapacity kept pricing under pressure, especially in agrochemical intermediates.
- MMA business scaling, but lumpy: Production grew ~49% on a 9-month basis, yet a single bulk shipment slipping from December to January materially skewed Q3 export revenue; the ramp-up remains gradual by design.
- Long-term EBITDA target reaffirmed: Management is confident in hitting a 20–25% EBITDA CAGR over 3–5 years, backed by volume growth, operating leverage, and product mix optimization.
- Zone IV repositioned for flexibility: The upcoming mega-block has been reconfigured from dedicated chemistries to a fungible, multi-purpose asset, allowing the company to chase margin and demand in real time.
- What to watch next quarter: Whether the nitrotoluene ramp-up and the slipped MMA shipment deliver the anticipated Q4 improvement, and if gross margins normalize as the aniline inventory impact clears.
Demand & Pricing Environment
- Volume recovery takes hold: Non-energy end-use applications like dyes, pigments, and polymer additives showed positive demand trends, while the pharma business sustained its recovery trajectory from FY24.
- Agrochemical inventory normalizes: Inventory levels in most end markets have normalized, but pricing pressure persists and is "potentially aggravated" by robust Chinese capacity.
- Polymer recovery faces policy risk: The polymer and additives segment continues to recover, though uncertainty surrounds 2025 demand due to potential U.S. policy changes.
- Base business stabilizes at low prices: Pricing levels have stabilized, albeit at levels management does not like; the focus now is on regaining volume and optimizing product mix as asset utilization improves.
- Chinese overcapacity is structural: The overcapacity situation in chains like PDA, NCB, and nitrotoluene is a mid- to long-term problem with no major incremental changes quarter-on-quarter.
Kotecha: "I think the overcapacity situation that we have in many of our product chains, especially in China, is a mid- to long-term problem and that will take some time to resolve, so no major incremental changes when it comes to quarter-on-quarter movement, especially in some chains like PDA, or even, for that matter, some of the chains which are linked to NCB and nitrotoluene, where Chinese capacity remains pretty robust."
MMA Business: Scaling & Mechanics
- Production ramps, revenue lags: On a 9-month basis, MMA production grew from ~59 kt to ~88 kt, but QoQ revenue growth was only ~10% because a large bulk shipment slipped from late December to early January and the company is building finished-goods inventory.
- Competitiveness proven in weak markets: The company placed volumes even with gasoline-naphtha spreads at 9.5, demonstrating product competitiveness for octane boosting; penetration in the global octane booster market remains "significantly low."
- Bulk shipping capability established: Bulk shipping operations began in Q3, with ongoing optimization to reduce operating costs; benefits may accrue from Q4 onwards.
- Solution-oriented business model: The value proposition varies by customer, spanning supply chain complexity management, large-volume cargo handling over long distances, and custom formulations based on a refiner's product portfolio.
- No bans anticipated: Management does not expect bans in current export geographies; as port operators and customers are educated on handling, usage scales up, with the U.S. and Middle East already commercially deploying the product.
- Gross margin temporarily depressed: Gross margin was impacted by aniline inventory build-up and pricing adjustments made to push MMA volumes; the aniline impact clears in Q3, so Q4 should offer a cleaner read on underlying gross margins.
Kotecha: "However, at the same time, I do want to highlight that, given the nature of the business, it does take time to crack new markets and new customers. And that's where we are saying that the ramp-up in the overall volume will be gradual and not a one-off event."
Zone IV: A Flexible Mega-Block
- Configuration fundamentally changed: The product mix has been made "rigid" compared to original plans from two years back; the domestic-export split is now revised to 60-40, targeting import-substitution products for the domestic market.
- Fungibility is the core thesis: Within the existing capex envelope, the company can now produce both chlorotoluene/downstream and dichlorotoluene/downstream chains; absolute capacity of individual molecules may decline, but the ability to switch between OCT, PCT, and DCT downstream products is built in.
- Phased commissioning underway: The next block (multi-purpose plant and calcium chloride plant) will be commissioned next, with remaining chlorotoluene value chain blocks expected in Q1 FY27; full commercial utilization is targeted within the first 1–1.5 years.
- Margin optimization by design: The flexibility lets management select products based on real-time margin and demand profiles, optimizing both utilization levels and profitability amid market volatility.
Kotecha: "The overall configuration of that zone itself, we have made it in such a way where it's kind of fungible and flexible, so our total capability to produce in terms of number of products would be far higher, but we could select the products depending on the margin profile and the demand profile at a particular given time frame."
Cost, Margins & Profitability
- Cost reduction program on track: 30–40% of the ₹150–200 crore cost reduction plan has been completed; the full exercise is expected to finish in the next 12–18 months.
- Product mix optimization incoming: As base utilization reaches certain levels, management will divert capacity toward better-margin products; this is expected to start playing out in the next few months.
- Forex impact is accounting, not cash: PAT was hit by a ₹23 crore mark-to-market loss on a long-term ECB loan from rupee depreciation; the actual outflow is spread over 9 years, and as a net exporter, the company should benefit from a weaker rupee in coming quarters.
- Tax rate to stay low: The current-year tax rate will remain marginally negative or near zero; FY26 should see a low single-digit rate.
- Renewable energy to cut power costs: Two PPAs signed for solar and hybrid power; one begins delivery this calendar year, the second in Q1 FY27, pushing the renewable share in total power purchase above 75%.
Kotecha: "As we get our asset utilizations up and volumes back, we are also able to optimize the product mix to ensure that we are diverting capacity where we are expecting better margin profiles and that will start to play out in the next few months."
Capex, Expansion & New Ventures
- Nitrotoluene and ethylation expansions commissioned: Nitrotoluene capacity expanded from 30 to 45 KTPA, and the ethylation facility from 8–10 KTPA to ~25–30 KTPA; both will ramp up through Q4 and beyond.
- MMA capacity now at 200 KTPA: The expansion positions the company as a market leader; further expansion is possible with minor investments if market conditions warrant.
- Plastic recycling JV incorporated: Aarti Circularity Limited (a wholly owned subsidiary) and Re Sustainability formed a JV for advanced chemical recycling of plastic waste; targets are 100 TPD in the first 18 months and 500 TPD by 2030, though revenue and profitability potential remain undisclosed.
- Capex tapering ahead: FY25 capex is guided at ₹1,300–1,500 crore; FY26 capex will be a bit lower than ₹1,000 crore, with subsequent spending linked to growth opportunities after Zone IV commissioning.
- New product development underway: The company is developing new products in the ethylation value chain and pursuing backward integration into select downstream products; all new developments involve 4–6 chemistry steps starting from bulk chemicals like NCB, DCB, PDA, or NT.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| EBITDA CAGR | 20% to 25% CAGR | Over 3 to 5 years |
| Long-term absolute EBITDA | ₹1,800 crore to ₹2,200 crore | In the 3-year plan |
| ROCE/ROIC target | 14% to 15% | In the 3-year plan |
| Cost reduction completion | Full ₹150–200 crore exercise | Next 12 to 18 months |
| Zone IV commissioning | All blocks gradually commissioned | Over next 12 to 15 months; chlorotoluene block by Q1 FY27 |
| Zone IV commercial utilization | Achieve commercial utilization | Within first 1 to 1.5 years of commissioning |
| PNCB capacity utilization | Ramp up to 80%-plus | Coming financial year |
| Renewable energy share | Exceed 75% of total power purchase | By Q1 FY27 |
| Plastic recycling JV capacity | 100 TPD, then 500 TPD | First 18 months; by 2030 |
| FY25 capex | ₹1,300 crore to ₹1,500 crore | FY25 |
| FY26 capex | A bit lower than ₹1,000 crore | FY26 |
| Tax rate | Low single-digit range | FY26 |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue | ₹2,035 cr, 14% higher QoQ and 8% higher YoY |
| EBITDA | ₹236 cr, grew 17% QoQ |
| PAT | ₹46 cr, impacted by forex mark-to-market loss of ₹23 cr on long-term ECB loan |
| Non-energy business volume growth | 14% YoY and 8% QoQ |
| Energy business volume growth | 10% QoQ |
| Exports | ₹1,009 cr, up from ~₹900 cr in Q2 FY25 |
| Capex incurred (Q3) | ₹380 cr |
| Capex incurred (9M FY25) | ₹1,020 cr |
| FY25 capex guidance | ₹1,300 cr to ₹1,500 cr, unchanged |
| FY26 capex guidance | a bit lower than ₹1,000 cr |
| Net debt | ~₹3,600 cr |
| Unhedged ECB loan exposure | ~$140 million, repayment over ~9 years |
| MMA production volume (9M FY25) | ~88 kt, up from ~59 kt in 9M FY24 |
| Long-term EBITDA guidance | ₹1,800 cr to ₹2,200 cr, targeting 20% to 25% CAGR EBITDA over 3 to 5 years |
| Long-term EBITDA margin assumption | 14% to 15% |
| Long-term ROCE/ROIC target | 14% to 15% |
| Renewable power share target | exceed 75% by Q1 FY27 |
| Plastic recycling JV capacity target | 100 TPD in first 18 months, 500 TPD by 2030 |
| Cost optimization plan progress | 30% to 40% completed of ₹150 cr to ₹200 cr plan |
| PNCB capacity utilization | ~75%, expected to ramp to 80%-plus in coming financial year |
| Zone IV domestic-export split | 60-40 |